Bristol Increases Legal Reserves For Wholesaler Inventory Liability By $300 Mil.
This article was originally published in The Pink Sheet Daily
Executive Summary
The company increases wholesaler-related litigation reserves for the second time in three months. Bristol also sets aside $100 mil. for product liability and other matters.
You may also be interested in...
Nefazodone Generics Stay On Market Following FDA Analysis Of Serzone Withdrawal
Bristol's voluntary withdrawal of the antidepressant was not due to safety or effectiveness reasons, FDA says. This distinction allows generic versions of Serzone to remain on the market and may help Bristol in its upcoming liability lawsuits.
Nefazodone Generics Stay On Market Following FDA Analysis Of Serzone Withdrawal
Bristol's voluntary withdrawal of the antidepressant was not due to safety or effectiveness reasons, FDA says. This distinction allows generic versions of Serzone to remain on the market and may help Bristol in its upcoming liability lawsuits.
Bristol Takes $455 Mil. Litigation Charge, Higher Than Earlier Expectations
Bristol-Myers Squibb increased its litigation reserves to $455 mil. in the second quarter, a charge that is $55 mil. higher than earlier expectations